Washington: The United States today released a 44-cent postal stamp in the honour of Mother Teresa, acknowledging her unrelenting humanitarian service for nearly half a century.
The Commission on Human Medicines said the "risks of rosiglitazone (Avandia) outweigh its benefits" and called for prompt action.
Clinical pharmacologist Yoon Loke of the University of East Anglia estimated that the drug causes around 1,000 extra heart attacks a year in Britain, reports the Daily Mail.
Avandia was approved by the European Medicines Agency in 2000 to help reduce blood sugar in patients with type 2 diabetes, the form that usually strikes in middle and old ages, reports the British Medical Journal.
It became one of the best-selling global drugs, with sales of more than £1.5 billion. In Britain, doctors wrote out more than a million prescriptions for it last year at a cost of around £30 million.
The warning, which raises concerns about the way drugs are tested and regulated, comes in the wake of calls for its withdrawal by the committee responsible for drug safety in the UK, three months ago.
But despite the warning to the general practitioners to alert them, patients were not informed and thousands are still on the drug.
Experts stressed that patients should not stop taking medication without first seeing their doctor - but urged doctors to review the way they treated diabetes.
Its manufacturer, GlaxoSmithKline, said: "Extensive research showed the drug was safe and effective".
PTI
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookies Setting
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device and the processing of information obtained via those cookies (including about your preferences, device and online activity) by us and our commercial partners to enhance site navigation, personalise ads, analyze site usage, and assist in our marketing efforts. More information can be found in our Cookies and Privacy Policy. You can amend your cookie settings to reject non-essential cookies by clicking Cookie Settings below.
Manage Consent Preferences
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work or you may not be able to login.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They are also used to limit the number of times you see an advert as well as help measure the effectiveness of an advertising campaign. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we may not know when you have visited our site, and may not be able to monitor its performance.